Array ( [0] => Applebot/0.1 [1] => facebookexternalhit/1.1 [2] => LinkedInBot/1.0 [3] => meta-externalagent/1.1 [4] => Amazonbot/0.1 [5] => BLEXBot/1.0 [6] => DotBot/1.2 [7] => Qwantbot/1.0_1997801 [8] => AhrefsBot/7.0 [9] => DataForSeoBot/1.0 [10] => MatchorySearch/1.3 [11] => WRTNBot/1.0 [12] => Sogou web spider/4.0 [13] => MojeekBot/0.11 [14] => Yeti/1.1 [15] => SeznamBot/4.0 [16] => SemrushBot-SI/0.97 [17] => MistralAI-User/1.0 [18] => Qwantbot/1.0 [19] => coccocbot-web/1.0 [20] => coccocbot-image/1.0 [21] => PlagAwareBot/3.2 [22] => Barkrowler/0.9 [23] => AwarioSmartBot/1.0 [24] => PetalBot [25] => archive.org_bot [26] => Iframely/1.3.1 [27] => LogRocket-AssetCacher [28] => Slackbot 1.0 [29] => node-fetch/1.0 [30] => MJ12bot/v1.4.8 [31] => MJ12bot/v2.0.0 [32] => Timpibot/0.9 [33] => AwarioBot/1.0 [34] => MJ12bot/v2.0.1 [35] => Qwantbot/1.0_2850318 [36] => SiteAuditBot/0.97 [37] => Scrapy/2.11.2 [38] => CCBot/2.0 [39] => MJ12bot/v2.0.2 [40] => Scrapy/2.13.3 [41] => WordPress/6.8.3 [42] => MJ12bot/v2.0.4 [43] => SemrushBot/7~bl [44] => Qwairy-Bot/1.0 [45] => Embedly/0.2 [46] => GeedoProductSearch [47] => SemrushBot [48] => vkShare [49] => inkrich [50] => Discordbot/2.0 [51] => IbouBot/1.0 [52] => trafilatura/1.6.3 [53] => AnsehnBot/1.0 [54] => WP-URLDetails/6.8.3 [55] => HubSpot Crawler [56] => ShapBot/0.1.0 [57] => udu/1.6.5 [58] => aiohttp/3.13.1 [59] => l9scan/2.0 [60] => Trident/5.0 [61] => SmartBotCrawler/1.0 [62] => ) The user agent is not in the allowed list.Array ( [0] => pingbot/2.0 [1] => Googlebot/2.1 [2] => ChatGPT-User/1.0 [3] => PerplexityBot/1.0 [4] => OAI-SearchBot/1.0 [5] => GPTBot/1.2 [6] => Perplexity-User/1.0 [7] => YandexBot/3.0 [8] => YandexFavicons/1.0 [9] => AdsBot-Google-Mobile [10] => AdsBot-Google [11] => Gemini-Deep-Research [12] => DuckAssistBot/1.1 [13] => DuckDuckBot/1.1 [14] => GoogleOther [15] => YandexRenderResourcesBot/1.0 [16] => YandexImages/3.0 [17] => DuckAssistBot/1.2 [18] => Baiduspider/2.0 [19] => Baiduspider-render/2.0 [20] => bingbot/2.0 [21] => YandexUserproxy [22] => Pingdom.com_bot_version_1.4_ [23] => GPTBot/1.3 [24] => PingdomPageSpeed/1.0 [25] => YandexMobileBot/3.0 [26] => OAI-SearchBot/1.3 [27] => ClaudeBot/1.0 [28] => OAI-SearchBot/1.3 [29] => ) The user agent is an allowed/known agent.
Infection Control Surveillance Solutions Market Size & Growth Forecast 2026–2035, By Segments (Component, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Base Year Value (2025)
USD 801.88 Million
CAGR (2026-2035)
13.1%
Forecast Year Value (2035)
USD 2.75 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035
Infection Control Surveillance Solutions Market Intelligence Snapshot:
-
Regional Market Dynamics:
- North America held 52.82% share due to widespread healthcare IT adoption, integrated surveillance platforms, infection prevention protocols, and continuous hospital monitoring systems.
- Asia Pacific is projected to grow at 14.67% CAGR driven by healthcare modernization, structured reporting systems, and shift from manual infection tracking to software-based surveillance tools.
-
Segment Momentum:
- Software held a 61.5% share in 2025 because it serves as the operational core for surveillance data capture, infection tracking, alert generation, analytics, and routine reporting across healthcare settings.
- Long Term Care Facilities are the fastest-growing end-use segment as providers expand infection monitoring capabilities to improve surveillance among vulnerable residents and strengthen day-to-day infection control practices.
-
Market Expansion Drivers:
- Rising prevalence of hospital-acquired infections driving adoption of advanced surveillance systems.
- Government infection control initiatives accelerating deployment of healthcare surveillance technologies.
- Increasing hospital digitization improving integration of real-time infection monitoring platforms.
-
Industry Adoption Constraints:
-
Leading Market Participants:
Prominent players in the infection control surveillance solutions market include Becton, Dickinson and Company (United States), Premier, Inc. (United States), Wolters Kluwer N.V. (Netherlands), Oracle Corporation (United States), Baxter International Inc. (United States), Merative (United States), RLDatix Ltd (United Kingdom), GOJO Industries, Inc. (United States), IQVIA Holdings Inc. (United States), Epic Systems Corporation (United States).
Global Market Forecast Snapshot:
-
Market Outlook:
- 2025 Market Size: USD 801.88 Million
- 2026 Market Size: USD 15.2 billion
- Projected Market Size: USD 2.75 Billion by 2035
- Growth Forecasts: 13.1% CAGR (2026-2035)
-
Regional and Segment Outlook:
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Software (Component) | Hospitals (End-use)
- Emerging Opportunity Segment: Services (Component) | Long Term Care Facilities (End-use)
Market Growth Drivers and Industry Trends
Rising prevalence of hospital-acquired infections driving adoption of advanced surveillance systemsAs healthcare providers face persistent pressure to detect hospital-acquired infections earlier and reduce avoidable clinical and financial burdens, the infection control surveillance solutions market is seeing stronger demand for systems that can continuously track infection signals across wards, laboratories, and patient records. Infection prevention teams are moving away from manual chart reviews and delayed reporting because rising case complexity makes retrospective monitoring too slow to support timely intervention. This is influencing market adoption toward platforms that automate case identification, flag unusual transmission patterns, and support faster isolation, cleaning, and treatment decisions, reinforcing demand for more embedded and data-driven surveillance capabilities.
Government infection control initiatives accelerating deployment of healthcare surveillance technologies
Public health mandates, accreditation requirements, and formal infection prevention programs are translating policy into purchasing activity for the infection control surveillance solutions market, particularly where healthcare facilities must document compliance, report infection events, and demonstrate measurable control processes. Hospitals and health systems tend to prioritize technologies that simplify standardized reporting and create auditable infection tracking workflows when regulatory scrutiny increases. This dynamic is strengthening market development for surveillance platforms that align with institutional governance needs, because buying decisions are often tied not only to clinical visibility but also to the ability to satisfy reporting obligations and support systemwide infection control protocols.
Increasing hospital digitization improving integration of real-time infection monitoring platforms
Wider adoption of electronic health records, laboratory information systems, and connected clinical workflows is making it more practical for providers to implement surveillance tools that operate on live data rather than fragmented manual inputs, encouraging market growth for the infection control surveillance solutions market. As hospitals digitize more of the care pathway, infection monitoring platforms can pull microbiology results, patient movement data, antibiotic usage, and clinical documentation into a unified view that sharpens detection accuracy and shortens response time. Integration is a decisive factor in purchasing behavior because facilities are more likely to adopt platforms that fit existing digital infrastructure, reduce duplicate work for infection prevention staff, and turn routine operational data into actionable outbreak intelligence.
Regional Demand Dynamics
Largest Region
North America
52.82% Market Share in 2025
North America held a 52.82% share of the infection control surveillance solutions market in 2025, reflecting the region’s entrenched use of digital monitoring tools across hospitals, health systems, and other care settings. Its leadership is underpinned by widespread healthcare IT adoption, established infection prevention protocols, and a stronger installed base of surveillance platforms that are integrated into day-to-day clinical workflows. In practice, providers in the region are more likely to rely on continuous data capture, automated alerting, and centralized reporting to track hospital-acquired infections, support compliance activity, and improve operational response times.
Asia Pacific is projected to expand at a 14.67% CAGR over the forecast period, with the infection control surveillance solutions market gaining momentum as healthcare providers modernize infection monitoring practices and broaden digital infrastructure. Growth is being fueled by rising implementation of surveillance systems in hospitals that need better visibility into infection trends, particularly as care networks scale and reporting requirements become more structured. Adoption is accelerating in practical terms because facilities are moving from manual tracking methods toward software-based surveillance that can streamline case detection, improve data consistency, and support faster intervention across high-volume healthcare environments.
| Regional Market Attractiveness & Strategic Fit Matrix | |||||
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub | Advanced | Developing | Advanced | Developing | Nascent |
| Cost-Sensitive Region | Medium | High | Medium | High | High |
| Regulatory Environment | Supportive | Neutral | Restrictive | Neutral | Restrictive |
| Demand Drivers | Strong | Moderate | Strong | Moderate | Weak |
| Development Stage | Developed | Developing | Developed | Emerging | Emerging |
| Adoption Rate | High | Medium | High | Medium | Low |
| New Entrants / Startups | Dense | Moderate | Dense | Sparse | Sparse |
| Macro Indicators | Strong | Stable | Strong | Stable | Weak |
No card data available for this language/report.
Segment Leadership and Growth Trends
Software held the dominant position in the infection control surveillance solutions market in 2025, accounting for a 61.5% share. its position is maintained through the central role software plays in capturing surveillance data, tracking infection patterns, generating alerts, and supporting routine reporting across care settings. Since infection control programs depend on continuous monitoring and usable analytics, software remains the operational core of deployment, which helps preserve its dominant share in the market.
Services are emerging as the fastest-growing part of the infection control surveillance solutions market as healthcare providers increasingly need support with implementation, system integration, customization, training, and ongoing optimization. Growth is being encouraged by the practical challenge of turning surveillance platforms into effective day-to-day workflows, especially where internal technical and infection prevention resources are limited. Compared with software alone, services gain momentum because they directly address execution gaps that can affect adoption and performance.
End-use Segment Analysis: Hospitals (Largest Segment) vs Long Term Care Facilities (Fastest-Growing Segment)
By 2025, hospitals represented the largest end-use segment in the infection control surveillance solutions market, with a 76.13% share. Their leadership reflects the high volume of patient interactions, greater exposure to healthcare-associated infection risks, and the need for structured surveillance across departments, units, and clinical workflows. Hospitals also rely heavily on timely infection tracking and reporting to support operational control, which reinforces their leading share in this market.
Long Term Care Facilities are the fastest-growing end-use segment in the infection control surveillance solutions market as these settings face increasing pressure to improve infection monitoring among vulnerable resident populations. Their growth is reinforced through the need for more consistent surveillance processes in environments where extended stays and close-contact care can heighten infection transmission concerns. Relative to more established hospital deployments, long term care facilities are gaining momentum because they are expanding the use of dedicated surveillance solutions from a lower base of adoption.
| Report Segmentation | |||
| Segment | Sub-Segment | Largest Segment | Fastest Growing Segment |
|---|---|---|---|
| Component | Software, Services | Software | Services |
| End-use | Hospitals, Long Term Care Facilities, Others | Hospitals | Long Term Care Facilities |
Read our Research ApproachCompetitive Landscape and Market Positioning
Company Profile
Business Overview Financial Highlights Product Landscape SWOT Analysis Recent Developments Company Heat Map Analysis
1. Becton Dickinson and Company (United States)
2. Premier Inc. (United States)
3. Wolters Kluwer N.V. (Netherlands)
4. Oracle Corporation (United States)
5. Baxter International Inc. (United States)
6. Merative (United States)
7. RLDatix Ltd (United Kingdom)
8. GOJO Industries Inc. (United States)
9. IQVIA Holdings Inc. (United States)
10. Epic Systems Corporation (United States)
The infection control surveillance solutions market is evolving through increasing adoption of data-driven monitoring systems and AI-supported infection tracking technologies. Healthcare providers are investing in real-time surveillance platforms that improve reporting accuracy, outbreak detection, and regulatory compliance management. Enhanced integration with hospital information systems is additionally strengthening operational efficiency and infection prevention strategies.
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Becton Dickinson and Company | May-25 | Becton Dickinson announced a USD 2.5 billion investment in U.S. manufacturing infrastructure alongside receiving FDA clearance for an integrated antimicrobial-resistance diagnostic. This expansion strengthens the company's production capacity and technical capabilities in the infection control and diagnostics space, positioning it to better meet institutional demand for advanced resistance detection and surveillance tools. |
| Becton Dickinson and Company | May-25 | Becton Dickinson launched the FACSDiscover A8 Cell Analyzer, incorporating spectral, real-time imaging technology for the analysis of over 50 biomarkers. This innovation enhances throughput and precision for infection research, enabling healthcare and laboratory facilities to accelerate data acquisition and improve investigative capabilities in complex infectious disease diagnostics. |
| Wolters Kluwer | Mar-25 | Wolters Kluwer deployed its AI Labs platform, powered by UpToDate, across 100 hospital systems. This initiative integrates generative AI with validated clinical content to support clinical surveillance and decision-making. The rollout represents a strategic effort to scale AI-driven insights within clinical workflows, directly enhancing the surveillance and identification of at-risk patient populations. |
Frequently Asked Questions
How large is the infection control surveillance solutions market?
The market revenue for infection control surveillance solutions is anticipated at USD 895.73 million in 2026.
What is the anticipated CAGR of the infection control surveillance solutions industry?
Infection Control Surveillance Solutions Market size is anticipated to rise from USD 801.88 million in 2025 to USD 2.75 billion by 2035 reflecting a CAGR surpassing 13.1% over the forecast horizon of 2026-2035.
How are healthcare providers transforming infection surveillance strategies to improve clinical response?
Healthcare organizations are replacing manual monitoring with automated surveillance platforms that detect infection patterns earlier, enabling faster intervention, improved case identification, and more effective infection prevention across clinical settings.
Why is hospital digitization strengthening demand for infection control surveillance solutions?
Integration with electronic health records, laboratory systems, and connected clinical workflows enables real-time infection monitoring, improving detection accuracy while reducing manual effort and supporting faster operational decision-making.
Why is Software the leading component in the infection control surveillance solutions market?
Software held a 61.5% share in 2025 because it serves as the operational core for surveillance data capture, infection tracking, alert generation, analytics, and routine reporting across healthcare settings.
What is supporting the rapid growth of Long Term Care Facilities in this market?
Long Term Care Facilities are the fastest-growing end-use segment as providers expand infection monitoring capabilities to improve surveillance among vulnerable residents and strengthen day-to-day infection control practices.
Why does North America lead the infection control surveillance solutions market?
North America held 52.82% share due to widespread healthcare IT adoption, integrated surveillance platforms, infection prevention protocols, and continuous hospital monitoring systems.
What is driving Asia Pacific growth in infection surveillance solutions?
Asia Pacific is projected to grow at 14.67% CAGR driven by healthcare modernization, structured reporting systems, and shift from manual infection tracking to software-based surveillance tools.
Who holds a significant market share in the infection control surveillance solutions landscape?
Prominent players in the infection control surveillance solutions market include Becton, Dickinson and Company (United States), Premier, Inc. (United States), Wolters Kluwer N.V. (Netherlands), Oracle Corporation (United States), Baxter International Inc. (United States), Merative (United States), RLDatix Ltd (United Kingdom), GOJO Industries, Inc. (United States), IQVIA Holdings Inc. (United States), Epic Systems Corporation (United States).
Our Clients
Why Choose Us
Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.
Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.
Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.
Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.
Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.
Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.
Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.
Select Licence Type
